David J Sher MD
Associate Professor of Radiation Oncology, UT Southwestern Medical Center
Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-8525
Fax+1 214-645-9233
Dr. Sher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2004 - 2008
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2003 - 2004
Harvard Medical SchoolClass of 2003
Certifications & Licensure
TX State Medical License 2015 - 2026
IL State Medical License 2011 - 2017
MA State Medical License 2004 - 2012
American Board of Radiology Radiation Oncology
Clinical Trials
- Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Dec 01
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation Start of enrollment: 2010 Dec 01
- Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer Start of enrollment: 2019 May 29
- Join now to see all
Publications & Presentations
PubMed
- The Future of Head and Neck Radiotherapy: Not Your Father's Three-Field.David J Sher, Yvonne M Mowery
Seminars in Radiation Oncology. 2025-04-01 - Contour uncertainty assessment for MD-omitted daily adaptive online head and neck radiotherapy.Chien-Yi Liao, Austen Matthew Maniscalco, Hengrui Zhao, Ti Bai, Byongsu Choi
Radiotherapy and Oncology. 2025-04-01 - Nodal Yield From Neck Dissection Predicts the Anti-Tumor Immune Response in Head and Neck Cancers.Shuqing Chen, Justin M Pyne, Yulun Liu, Youstina Abraham, Zhuoyu Wen
Head & Neck. 2025-04-01
Other
- Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The larynx and hypopharynxSher DJ, Brockstein BE, Stenson KM
http://www.uptodate.com/contents/treatment-of-locoregionally-advanced-stage-iii-and-iv-head-and-neck
UpToDate, Wolters Kluwer Health - 2013-02-25
Press Mentions
EpicentRx Publishes Phase 2 Results for RRx-001 as an Anti-Mucositis Agent in Patients Receiving Radiation for Head and Neck CancersJanuary 19th, 2023
How Crypto Is Fighting Coronavirus: Hacks, Info, PerspectivesMarch 16th, 2020
Study: Surgery, Radiation Therapy Equally Effective in Treating OPSCCSeptember 25th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
